Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
12.00
0.00 (0.00%)
Dec 31, 2024, 4:00 PM EST - Market closed
Palvella Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 4.84 | 3.08 | 4.16 |
| Research & Development | 6.31 | 8.79 | 13.88 |
| Operating Expenses | 11.15 | 11.87 | 18.04 |
| Operating Income | -11.15 | -11.87 | -18.04 |
| Interest Expense | -4.16 | - | -10.36 |
| Interest & Investment Income | - | 6.27 | - |
| Other Non Operating Income (Expenses) | -0.74 | 1.2 | -0.17 |
| EBT Excluding Unusual Items | -16.04 | -4.41 | -28.58 |
| Other Unusual Items | 23.1 | 23.1 | - |
| Pretax Income | 7.06 | 18.69 | -28.58 |
| Income Tax Expense | - | - | -1.03 |
| Net Income | 7.06 | 18.69 | -27.55 |
| Preferred Dividends & Other Adjustments | 14.81 | 14.81 | - |
| Net Income to Common | -7.75 | 3.88 | -27.55 |
| Shares Outstanding (Basic) | 6 | 6 | 6 |
| Shares Outstanding (Diluted) | 6 | 6 | 6 |
| Shares Change (YoY) | 0.02% | 1.36% | - |
| EPS (Basic) | -1.36 | 0.68 | -4.82 |
| EPS (Diluted) | -1.36 | 0.67 | -4.82 |
| Free Cash Flow | -7.87 | -13.7 | -14.84 |
| Free Cash Flow Per Share | -1.38 | -2.36 | -2.59 |
| EBIT | -11.15 | -11.87 | -18.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.